Combination comprising signal transduction inhibitor and epothilone derivative

Combination comprising signal transduction inhibitor and epothilone derivative

  • CN 1,511,036 A
  • Filed: 02/26/2002
  • Published: 07/07/2004
  • Est. Priority Date: 02/27/2001
  • Status: Active Application
First Claim
Patent Images

1. cooperative programs, it comprises can be simultaneously, respectively or use in succession(a) be selected from PDGF (deriving from hematoblastic somatomedin) receptor tyrosine kinase inhibitors and can reduce the active active component of epidermal growth factor (EGF) signal transduction inhibitor and(b) epothilone derivate of formula I and optional at least a pharmaceutically suitable carrier,

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×